Imatinib as a cause of cystoid macular edema following uneventful phacoemulsification surgery
- PMID: 16473243
- DOI: 10.1016/j.jcrs.2005.10.029
Imatinib as a cause of cystoid macular edema following uneventful phacoemulsification surgery
Abstract
Cystoid macular edema (CME) is an important cause of visual impairment following phacoemulsification surgery. Imatinib is a new drug that is being used as adjunctive therapy in the management of various malignancies. A reported ocular side effect of this drug is spontaneous retinal edema. We report the case of a patient on imatinib who developed significant premature CME following uneventful phacoemulsification surgery. This resolved soon after cessation of imatinib therapy, and there was an improvement in visual acuity.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
